Insider trades
James N. Topper, Director of Phathom Pharmaceuticals PHAT, has filed 19 purchases and 1 sale on the open market. The latest trade was on 05/19.
James N. Topper
Director
- Company
- Phathom Pharmaceuticals PHAT
- First filing
- 23/01/05
- Trades
- 48 trades
- Buys / sales
- 19 / 1
- 12-month net buying
- No record
- Last trade
- 05/19
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
| Open-market buy | 25/09/26 | 25/09/30 | 666,666 sh | $18.00 | $11,999,988 | +14.6% | |
| Open-market buy | 25/09/15 | 25/09/17 | 660 sh | $23.70 | $15,642 | +0.0% | |
| Open-market buy | 25/09/08 | 25/09/10 | 1,260 sh | $24.99 | $31,487.4 | +0.0% | |
| Open-market buy | 25/08/11 | 25/08/13 | 471 sh | $23.98 | $11,294.58 | +0.0% | |
NAMS | Open-market buy | 25/06/24–25/06/25 | 25/06/26 | 3,780 sh2 trades | $18.37avg. | $69,451.2 | +0.1% |
| Open-market buy | 25/06/16 | 25/06/18 | 8,584 sh | $19.50 | $167,388 | +0.3% | |
| Open-market buy | 25/05/21 | 25/05/23 | 3,780 sh | $3.86 | $14,590.8 | +6.8% | |
PHAT | Open-market buy | 25/05/13–25/05/14 | 25/05/15 | 7,420 sh2 trades | $3.30avg. | $24,455.2 | +15.4% |
PHAT | Open-market buy | 25/05/09–25/05/12 | 25/05/13 | 48,203 sh3 trades | $3.17avg. | $152,834.6 | No record |
| Open-market buy | 25/03/26 | 25/03/28 | 1,135 sh | $22.49 | $25,526.15 | +0.0% | |
| Open-market buy | 25/03/04 | 25/03/06 | 4,005 sh | $21.02 | $84,185.1 | +0.1% | |
| Open-market buy | 24/09/16 | 24/09/17 | 625,000 sh | $16.00 | $10,000,000 | +15.9% | |
| Open-market sale | 24/04/25 | 24/04/29 | 19 sh | $64.57 | $1,226.83 | −0.0% | |
| Open-market buy | 24/04/04 | 24/04/08 | 8,850 sh | $14.50 | $128,325 | +0.1% | |
| Open-market buy | 24/03/26 | 24/03/28 | 8,429 sh | $21.50 | $181,223.5 | +0.3% | |
| Open-market buy | 23/10/24 | 23/10/26 | 80,000 sh | $2.50 | $200,000 | +0.9% |
